Rigel Pharmaceuticals, Inc. (RIGL)
39.65
-6.06
(-13.26%)
USD |
NASDAQ |
Nov 06, 16:00
39.60
-0.05
(-0.13%)
After-Hours: 20:00
Rigel Pharmaceuticals Market Cap : 739.63M for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 06, 2026 | 739.63M |
| November 05, 2026 | 852.67M |
| November 04, 2026 | 956.76M |
| November 03, 2026 | 911.43M |
| November 02, 2026 | 942.58M |
| October 30, 2026 | 957.13M |
| October 29, 2026 | 959.74M |
| October 28, 2026 | 946.50M |
| October 27, 2026 | 942.95M |
| October 26, 2026 | 931.02M |
| October 23, 2026 | 897.81M |
| October 22, 2026 | 911.43M |
| October 21, 2026 | 911.80M |
| October 20, 2026 | 897.44M |
| October 19, 2026 | 871.51M |
| October 16, 2026 | 857.52M |
| October 15, 2026 | 881.40M |
| October 14, 2026 | 873.38M |
| October 13, 2026 | 879.34M |
| October 12, 2026 | 910.50M |
| October 09, 2026 | 915.53M |
| October 08, 2026 | 908.82M |
| October 07, 2026 | 895.20M |
| October 06, 2026 | 860.13M |
| October 05, 2026 | 891.47M |
| Date | Value |
|---|---|
| October 02, 2026 | 879.53M |
| October 01, 2026 | 876.17M |
| September 30, 2026 | 898.19M |
| September 29, 2026 | 911.99M |
| September 28, 2026 | 920.76M |
| September 25, 2026 | 898.74M |
| September 24, 2026 | 893.34M |
| September 23, 2026 | 897.81M |
| September 22, 2026 | 910.68M |
| September 21, 2026 | 878.41M |
| September 18, 2026 | 870.02M |
| September 17, 2026 | 855.28M |
| September 16, 2026 | 829.73M |
| September 15, 2026 | 827.49M |
| September 14, 2026 | 845.95M |
| September 11, 2026 | 881.21M |
| September 10, 2026 | 881.96M |
| September 09, 2026 | 880.84M |
| September 08, 2026 | 883.64M |
| September 04, 2026 | 907.89M |
| September 03, 2026 | 904.71M |
| September 02, 2026 | 921.88M |
| September 01, 2026 | 886.06M |
| August 31, 2026 | 861.44M |
| August 28, 2026 | 867.03M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cytokinetics, Inc. | 7.475B |
| Inovio Pharmaceuticals, Inc. | 100.05M |
| United Therapeutics Corp. | 23.82B |
| Verastem, Inc. | 760.95M |
| Marker Therapeutics, Inc. | 14.89M |
Market Cap Related Metrics
| PE Ratio | 2.429 |
| PS Ratio | 2.801 |
| PEG Ratio | 0.0121 |
| Price to Book Value | 1.739 |
| Price to Free Cash Flow | 85.74 |
| Price | 39.65 |
| Earnings Yield | 41.17% |
| PEGY Ratio | 0.0121 |
| Operating PE Ratio | 8.905 |
| Normalized PE Ratio | 2.428 |